Zevra Therapeutics (ZVRA) Goodwill (2023 - 2026)

Zevra Therapeutics' Goodwill history runs 4 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $4.7 million, changed 0.02% from the prior year.
• Goodwill was $4.7 million for Q1 2026 at Zevra Therapeutics, roughly flat from $4.7 million in the prior quarter.
• Across five years, Goodwill topped out at $4.7 million in Q4 2023 and bottomed at $4.7 million in Q2 2024.
• A 4-year average of $4.7 million and a median of $4.7 million in 2023 frame the typical range for Goodwill.
• Peak annual rise in Goodwill reached 0.02% in 2025, while the deepest fall reached 0.02% in 2025.
• Zevra Therapeutics' Goodwill stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then slipped by 0.02% to $4.7 million in 2025, then gained by 0.02% to $4.7 million in 2026.
• Business Quant data shows ZVRA's Goodwill at $4.7 million in Q1 2026, $4.7 million in Q4 2025, and $4.7 million in Q3 2025.